| P2093 | author name string | Nina Mikirova | |
| | Ronald Hunninghake | |
| P2860 | cites work | Progress and problems in understanding and managing primary Epstein-Barr virus infections | Q24597706 |
| | Vitamin D and the anti-viral state | Q24613615 |
| | On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis | Q24645207 |
| | Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration | Q24648673 |
| | Vitamin C: update on physiology and pharmacology | Q24654791 |
| | EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15 | Q28302555 |
| | Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells | Q28323479 |
| | Pharmacological Concentrations of Ascorbic Acid Are Required for the Beneficial Effect on Endothelial Vasomotor Function in Hypertension | Q61704097 |
| | Effects of ascorbate on leucocytes: Part IV. Increased neutrophil function and clinical improvement after oral ascorbate in 2 patients with chronic granulomatous disease | Q67006070 |
| | Mechanism of inactivation of bacteriophage deltaA containing single-stranded DNA by ascorbic acid | Q67367893 |
| | The influence of ultraviolet irradiation, L-ascorbic acid and calcium chloride on the induction of interferon in human embryo fibroblasts | Q70536182 |
| | Vitamin C and immunity: influence of ascorbate on prostaglandin E2 synthesis and implications for natural killer cell activity | Q70972326 |
| | Effect of vitamin C supplements on cell-mediated immunity in old people | Q70993808 |
| | Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study | Q71237037 |
| | [An in vitro study on the pharmacological ascorbate treatment of influenza virus] | Q84894651 |
| | Acyclovir for treatment of infectious mononucleosis: a meta-analysis | Q33890661 |
| | Vitamin C pharmacokinetics: implications for oral and intravenous use. | Q33977273 |
| | Epstein-Barr virus entry into cells | Q34076007 |
| | Molecular virology of Epstein-Barr virus | Q34225554 |
| | Infectious mononucleosis and Epstein-Barr virus | Q34367240 |
| | Human cytomegalovirus activates glucose transporter 4 expression to increase glucose uptake during infection | Q34529843 |
| | Epstein-Barr virus and systemic lupus erythematosus | Q34555410 |
| | Immune-enhancing role of vitamin C and zinc and effect on clinical conditions | Q34563654 |
| | Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis | Q34565138 |
| | Antiviral effects of ascorbic and dehydroascorbic acids in vitro | Q34835774 |
| | Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus | Q35110891 |
| | Latent and lytic Epstein-Barr virus replication strategies | Q35896249 |
| | Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals | Q36230977 |
| | Therapeutic efficacy of high-dose vitamin C on acute pancreatitis and its potential mechanisms | Q36308895 |
| | Ascorbic acid inhibits replication and infectivity of avian RNA tumor virus | Q36388732 |
| | Intravenous vitamin C in the treatment of shingles: results of a multicenter prospective cohort study | Q36577734 |
| | Epstein-Barr virus and human diseases: recent advances in diagnosis | Q36633160 |
| | The curiously suspicious: a role for Epstein-Barr virus in lupus | Q36677016 |
| | Update: effects of antioxidant and non-antioxidant vitamin supplementation on immune function | Q36848695 |
| | The paradoxical effects of vitamin D on type 1 mediated immunity | Q37079271 |
| | Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients | Q37116018 |
| | Ascorbic acid acts as an inhibitory transmitter in the hypothalamus to inhibit stimulated luteinizing hormone-releasing hormone release by scavenging nitric oxide | Q37121863 |
| | The role of vitamin D in prevention and treatment of infection | Q37131135 |
| | Evidence-based approach for interpretation of Epstein-Barr virus serological patterns. | Q37374926 |
| | Immunosuppression in viral infections | Q39506389 |
| | Transport of ascorbic acid and other water-soluble vitamins | Q39641557 |
| | Effect of Ascorbic Acid, Sodium Salicylate, and Caffeine on the Serum Interferon Level in Response to Viral Infection | Q39944970 |
| | In vitro effect of ascorbic acid on infectivity of herpesviruses and paramyxoviruses. | Q40206987 |
| | Resolution of the facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid | Q41283900 |
| | Effect of high-dose intravenous vitamin C on inflammation in cancer patients | Q42405766 |
| | Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain | Q43289412 |
| | Diagnosis of atypical cases of infectious mononucleosis | Q43628084 |
| | Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. | Q44014362 |
| | Intravenous ascorbic acid: protocol for its application and use. | Q44656645 |
| | Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasma to ex vivo lipid peroxidation | Q44761602 |
| | Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis | Q45406581 |
| | Differential compartmentalization of brain ascorbate and glutathione between neurons and glia | Q48534216 |
| | Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid | Q49140908 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| | vitamin C | Q199678 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 725-732 | |
| P577 | publication date | 2014-05-03 | |
| P1433 | published in | Medical Science Monitor | Q15756323 |
| P1476 | title | Effect of high dose vitamin C on Epstein-Barr viral infection | |
| P478 | volume | 20 | |